Sphere formation assay revealed that fisetin reduced the cancer stemness promoted by gemcitabine in human PANC-1 cells and KPC mice KPC203 cells, as well as the proportion of CD44+/CD24+ cells among PANC-1 cells, further proving the results (Fig. 7c–e). This evidence concerns the gene CD44 and cancer.